S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCI Pharmtech Inc
Research & Development Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Research & Development
-NT$45.8m
CAGR 3-Years
-21%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
Y
YungShin Global Holding Corp
TWSE:3705
Research & Development
-NT$330.6m
CAGR 3-Years
-2%
CAGR 5-Years
4%
CAGR 10-Years
0%
Formosa Laboratories Inc
TWSE:4746
Research & Development
-NT$824.9m
CAGR 3-Years
-21%
CAGR 5-Years
-14%
CAGR 10-Years
-15%
ScinoPharm Taiwan Ltd
TWSE:1789
Research & Development
-NT$333.6m
CAGR 3-Years
-11%
CAGR 5-Years
-5%
CAGR 10-Years
3%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Research & Development
-NT$767m
CAGR 3-Years
-25%
CAGR 5-Years
-19%
CAGR 10-Years
-25%
Standard Chem & Pharm Co Ltd
TWSE:1720
Research & Development
-NT$284.3m
CAGR 3-Years
-16%
CAGR 5-Years
-6%
CAGR 10-Years
-2%

See Also

What is SCI Pharmtech Inc's Research & Development?
Research & Development
-45.8m TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Research & Development amounts to -45.8m TWD.

What is SCI Pharmtech Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-3%

Over the last year, the Research & Development growth was -1%. The average annual Research & Development growth rates for SCI Pharmtech Inc have been -21% over the past three years , -4% over the past five years , and -3% over the past ten years .

Back to Top